An organ-on-chip disease model approach, including “pre-clinical trial-on-chip” is introduced for understanding of human autoimmune disease pathophysiology and drug development.
No takes yet. Share an insight, caveat, or question.
Stolpe et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: